PSTX - Poseida Therapeutics EPS misses by $0.08 November, 12 2020 04:45 PM Poseida Therapeutics Inc. Poseida Therapeutics (PSTX): Q3 GAAP EPS of -$0.63 misses by $0.08.Cash, cash equivalents and marketable securities of $341.5M.Press Release For further details see: Poseida Therapeutics EPS misses by $0.08